VIENNA – Patients treated with an anti–tumor necrosis factor drug had a 5% annual rate of developing one or more psoriasiform skin lesions in a review of more than 400 patients who received these...
VIENNA – Patients treated with an anti–tumor necrosis factor drug had a 5% annual rate of developing one or more psoriasiform skin lesions in a review of more than 400 patients who received these...
PHILADELPHIA - The risk of both colorectal cancer and CRC-related mortality can be reduced in patients with inflammatory bowel disease by adhering to guideline-directed colonoscopy surveillance...
VIENNA – Patients with first-episode, uncomplicated diverticulitis can safely be managed by observation alone without routine antibiotic treatment, based on results from a prospective, controlled,...
Counseling adults about their individual risk of colorectal cancer generally did not convince them to seek screening for the disease, according to a randomized controlled trial reported online...
Counseling adults about their individual risk of colorectal cancer generally did not convince them to seek screening for the disease, according to a randomized controlled trial reported online...
LAS VEGAS – Laparoscopic splenectomy has become the preferred surgical approach in the literature, but the number of such procedures performed in the United States remains relatively low, according...
A rectal foam formulation of 2% budesonide has been approved by the Food and Drug Administration for treating distal ulcerative colitis, the manufacturer, Salix Pharmaceuticals, has...
The first combination pill to treat chronic hepatitis C virus genotype 1 infection was approved by the Food and Drug Administration Oct. 10.
The once-daily tablet under the trade name Harvoni...
MADRID – Results from a phase III trial of a new drug, TAS-102, that mimics the action of fluorouracil showed that it significantly boosted overall survival in heavily pretreated patients with...